ATS 2018 International Conference

PI3kinase/mTOR Inhibition Alters Global Metabolism in IPF Patients: Exploratory Biomarker Analysis from a Phase I Proof of Mechanism Study [Board No. 912]

Location: Board no. 912

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Tuesday

May

9:15 AM

11:15 AM

Speaker(s)/Author(s)

Rachel C. Chambers

PhD
Univ Coll London;University College London

Carmel B. Nanthakumar

PhD
GlaxoSmithKline

Yim Man

BSc
GlaxoSmithKline

Pauline T. Lukey

PhD
GlaxoSmithKline

Toby M. Maher

MD, MSc, PhD, FRCP
Imperial College;Imperial College London;Imperial College, London;National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Hare;Royal Brompton and Harefield NHS

William Fahy

MA, MSc, MBBS, FFPM
GlaxoSmithKline;GSK

Adam Taylor

BSc
GlaxoSmithKline

Richard Marshall

MD, MRCP(UK), MBBS, BSc(Hons), PhD
GlaxoSmithKline

Paul Francis. Mercer

BSc, PhD
University College London

View Abstract

PI3kinase/mTOR Inhibition Alters Global Metabolism in IPF Patients: Exploratory Biomarker Analysis from a Phase I Proof of Mechanism Study

Parent Sessions

C28 - ROLE OF CELLULAR CROSS TALK IN LUNG HOMEOSTASIS AND AGING...
05-22-2018 9:15 AM - 11:15 AM

Event